NYNadezhda V. Yuminova

Nadezhda V. Yuminova

*This is an algorithmically generated author record based on publicly available information.

Nadezhda V. Yuminova has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Effect of hemagglutinin from influenza virus A/BANGKOK/1/1979(H3N2) (Orthomyxoviridae, Alphainfluenzavirus) on the permeability of artificial lipid membranes for water

    by Контаров Николай Александрович, Nikolay A. Kontarov, Погарская Ирина Владимировна, Irina V. Pogarskaya, Долгова Екатерина Игоревна, Ekaterina I. Dolgova, Бахромеева Анна Андреевна, Anna A. Bachromeeva, Контарова Елена Олеговна, Elena O. Kontarova, et al.

    The aim of the study was to investigate structural changes in artificial phospholipid membranes induced by interaction with influenza virus hemagglutinin (HA). Materials and methods. Model membranes and liposomes composed of synthetic phosphatidylcholine (PC) were analyzed using spectrophotometry and electrokinetic potential measurements. Results. HA translocation across the membrane was demonstrated for the first time, with a permeability coefficient (PHA) of 1,33 × 10−10 cm/s at 10−6 M HA. HA interaction with PC liposomes increased their positive ζ-potential to (35 ± 0,4) mV, confirming surface adsorption. Temperature dependences of liposome swelling rates peaked at 10−6 and 10−5 M HA, while 10−4 M HA caused liposome disruption due to critical swelling. The peak swelling temperature shifted upward from T = 315 K (at 10−6 M) to T = 330 K for the 10−5 M concentration. This temperature shift indicates a thermotropic gel-to-liquid crystal phase transition within the membrane. This phase transition expands the area per phospholipid molecule and increases the spacing between hydrocarbon tails, leading to enhanced water permeability and particle swelling. Conclusion. The incorporation of HA into the lipid bilayer triggers conformational rearrangements (kinks, jogs) and enhances membrane water permeability via a thermotropic phase transition, resulting in liposome swelling and, at higher HA concentrations, their subsequent rupture.

  • Open Access

    Method for determining infectious and hemagglutinating titer of influenza A/Mallard Pennsylvania/10218/84 (H5N2) virus by changing the microviscosity of the viral membrane after interaction with phospholipid modifiers using cholesterol free liposomes as an example

    by Nikolay A. Kontarov, Irina V. Pogarskaya, Ekaterina I. Dolgova, Elena O. Kontarova, Vladimir V. Pomazanov, Ramis R. Gafarov, Sefaddin G. Mardanly, Nadezhda V. Yuminova

    Introduction. The antiviral action of a number of drugs is associated with their modification of the lipid membrane of viruses. One of the possible mechanisms of such modification of the viral membrane is the extraction of cholesterol from the membranes of virions. Objective of the study. A method has been developed for determining the infectious and hemagglutinating titer of avian influenza virus by changing the microviscosity of the viral membrane after incubation with phospholipid modifiers, using cholesterol-free liposomes consisting of phosphatidylcholine and phosphatidylethanolamine in a molar ratio of 1 : 2 for 48 hours as an example. Materials and methods. The extraction process was confirmed by two methods: gel filtration with radioactively labeled liposomes and virions, and by changing the polarization value of the fluorescent probe 1-anilinonaphthalene-8-sulfonate anion (8-ANS) in the viral membrane. Results. A correlation was found between the change in infectious and hemagglutinating titer and the microviscosity of the viral membrane. Conclusion. In this regard, it seems possible to use this dependence to determine the infectious and hemagglutinating activity of the influenza virus within one serotype in clinical laboratory diagnostics, using various fluorescent probes. It should be noted that not only liposomes of a certain composition can be used as lipophilic modifiers of the viral membrane, but also such compounds as ethylene glycol, erythritol, glycerol.

  • Open Access

    The study of the mortality characteristics of SARS-CoV-2 in the territory of the Russian Federation in 2020–2023 using the secondorder phase transition model

    by N. V. Yuminova, N. A. Kontarov, E. I. Dolgova

    Coronovirus SARS­CoV­2 has become a serious test for the entire global community in 2020. Its appearance and high speed of spread forced the heathcare system to reorient itself. In our work we focused on studying the mortality data from COVID­19 in Russia in 2020­2023. The exponential mortality increase is considered from the point of view of a secondorder phase transition. Also, using the Hurst method, we searched for the presence of a trend in mortality rate from year to year. Additional criteria are proposed in making decisions on the introduction and removal of restrictive measures. The obtained results should help in solving epidemiological problems when faced with a new infectious agent.

  • Open Access

    Assesment of spatial dynamics of COVID-19 in the territory of the Russian Federation in 2020–2023

    by N. V. Yuminova, N. A. Kontarov, E. I. Kontarov

    SARS-CoV-2 virus, first isolated in China in 2019, launched an epidemic and paralysed global health care in just a few mounth. In this article we present the results of a mathmatical analysis of data on morbidity for COVID-19 in Russia in 2020–2023. The structural characteristics of morbidity from this disease for the population of Moscow, St. Petersburg and Sevastopol are given based on the calculation of the Ryabtsev coefficient. The territorial concentration of morbidity in Russia was assessed dynamicaly by calculating the Herfindahl-Hirshman index.

  • Open Access

    Preventive Efficacy, Safety, Immunogenic Activity, and Evaluation of Post-Vaccination Responses Following Immunization with Combined Trivalent Vaccine Vaktrivir (Measles-Rubella-Parotitis) in Premature Infants

    by Vadislav V. Semerikov, Nina O. Yаkobyuk, Lyudmila V. Sofronova, Nadezhda V. Yuminova, Natalia N. Vorobjeva, Nikolay A. Kontarov, Н. О. Якобюк, Н. В. Юминова

    Background. Registration of combined trivalent vaccine Vaktrivir (measles-rubella-parotitis) in Russia necessitates studies on its preventive efficacy, safety, immunogenic activity, and post-vaccination responses following the immunization of premature infants. Objective. The aim of the study is to evaluate efficacy, safety, and immunogenic activity of combined trivalent vaccine (measles-rubella-parotitis) and level of post-vaccination responses following the immunization of premature infants. Methods. Experimental studies were conducted to evaluate safety, immunogenicity, and postvaccinal responses after immunization of premature infants with combined within prospective comparative clinical observation. Results. Administration of the combined trivalent vaccine Vaktrivir (measles-rubella-parotitis) in premature infants has shown: no cases of measles, rubella or parotitis among vaccinated persons within prospective clinical observation for 2 years; no disturbances in parameters of clinical blood analysis, biochemical blood count, total IgE, IgA, IgM, IgG (immunogram), or urine analysis among vaccinated children over time; no subjective perceptions, adverse events signs at physical examination among vaccinated compared to baseline parameters; low post-vaccination reactions (6.7%) and similar tolerance of trivalent vaccine Vaktrivir among full-term infants (3.3%) (p = 0.301). Conclusion. Administration of the combined trivalent vaccine Vaktrivir (measles-rubella-parotitis) in premature infants has demonstrated high safety profile and immunogenic properties for measles, rubella and parotitis components, good tolerability, and low post-vaccination responses after immunization, comparable to vaccination of full-term infants.


  • Open Access

    Standard definition of a clinical case of mumps and diagnostic effectiveness of the test systems used in the modern period

    by Vadislav V. Semerikov, Lyudmila V. Sofronova, Nina O. Postanogova, Nadezhda V. Yuminova, Ekaterina I. Dolgova, Natalia N. Vorobyova, Воробьева Наталья Николаевна

    Introduction. Registration of regular epidemic outbreaks of mumps infection among young people, difficulties in the clinical diagnosis of the disease, the presence of specific clinical manifestations in adults with a severe course of infection make it necessary the improvement of the quality of diagnosis of the disease. The aim of the work is to develop a standard definition of a clinical case of mumps and to conduct a comparative assessment of the effectiveness of the diagnostic test systems used for mumps diagnostics based on the determination of their sensitivity and specificity. Materials and methods. To develop a standard definition of a clinical case of mumps based on ten combined clinical and laboratory parameters, a mathematical model was built using the logistic regression method. The study included 84 patients with mumps infection (main group) and 66 patients with non-epidemic sialoadenitis (comparison group). For a comparative evaluation of the diagnostic systems VectoParotitis-IgM, VectoParotitis-IgG, ELISA-Mumps-IgM, ELISA-Mumps-IgG, Anti-Mumps Virus ELISA-IgM, and Anti-Mumps Virus ELISA-IgG, a blood serum samples from patients (n = 41) with a diagnosis mumps? were tested in dynamics to assess their sensitivity, specificity, and diagnostic effectiveness. Results. The clinical symptom dry mouth increased the chance of diagnosing mumps by 13.7 times, the presence of bilateral lesions of the salivary glands by 6.5 times, the increase in the level of diastase in the urine by 3.2 times. The coefficient of determination R2 was 61.1; the sensitivity was 93% and the specificity 67%; p 0.001. Diagnostic effectiveness of Anti-Mumps Virus ELISA-IgG test system was 84.4%, ELISA-Mumps-IgG 87.2%, and "VectoParotitis-IgG" 88.5%. Conclusions. Based on the combination of following clinical symptoms observed simultaneously in patient, of the general weakness, dry mouth, bilateral lesions of the salivary glands, an increase in the level of diastase in the urine, it is possible to establish a clinical diagnosis of mumps with a probability of 81%. The highest diagnostic effectiveness of domestically manufactured test systems for quantitation of IgG antibodies to mumps virus in sick people has been demonstrted.


  • Open Access

    MUMPS: ACHIEVEMENTS, PROBLEMS AND WAYS OF SOLUTION

    by V. V. Semerikov, N. V. Yuminova, N. O. Postanogova, L. V. Sofronova

    The aim. The article highlights the current state of the problem of mumps in the world and the Russian Federation.Materials and methods. The materials of the study were electronic resources WHO infection control, Cohrane, Elsevier, ScienceDirect, CDC infection diseases database, PubMed, eLibrary, CyberLeninka. The research methods were the analysis and generalization of scientific literature. The assessment is presented by the immunological structure of the population in different age groups to mumps (n = 593) in the study area (2018) according to the data of the Center for Hygiene and Epidemiology in the Perm Territory.Results. The spread of mumps is found to be widespread and uneven in different regions of the world in the form of sporadic cases and large epidemic outbreaks, despite the world practice of vaccine prevention of mumps. Analysis of the immunological structure to mumps in different age groups revealed a fairly high number of seronegative individuals (the largest number was found among adults aged 20–39 years) in the study area (2018). A decrease in the tension of post-vaccination immunity is the main cause for the emergence of an outbreak among the adult population, in addition to vaccination failures among vaccinated children. The immune defenses created by the vaccine strain do not have the same intensity and duration as with natural infection, and some genotypes of “wild” variants of the mumps virus can break through the immune barrier and cause disease. Antigenic differences between vaccine and circulating strains, low inoculation dose can weaken immunity and reduce the effectiveness of mass vaccine prevention.Conclusion. Ways of solving the problem were proposed to forestall an unfavorable epidemic situation with mumps.


  • Open Access

    Epidemic Mumps in Russia: Epidemic Situation, Key Challenges and Solutions

    by V. V. Semerikov, N. V. Yuminova, N. O. Postanogova, L. V. Sofronova, N. A. Kontarov

    Эпидемический паротит в России: эпидемическая ситуация, основные задачи и пути решения